Literature DB >> 19347300

Gastric carcinogenesis and Helicobacter pylori infection.

Christine Varon1, Jean-François Mosnier, Philippe Lehours, Tamara Matysiak-Budnik, Francis Mégraud.   

Abstract

Helicobacter pylori is the most frequent cause of infection-induced cancer worldwide. Gastric carcino-genesis is the consequence of the important and life-long inflammation induced by H. pylori in the stomach. Gastric carcinogenesis, can be studied in many ways. In this chapter, we focus on some aspects concerning the bacteria, and others concerning the host. On the bacterial side, the methods exploring the presence of the cag pathogenicity island including cagA and the consequences on epithelial cells are presented. On the host side, tissue microarray, immunohistochemistry and chromogenic in situ hybridization (CISH) are described.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19347300     DOI: 10.1007/978-1-59745-447-6_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Oxidative DNA damage as a potential early biomarker of Helicobacter pylori associated carcinogenesis.

Authors:  Yasir Raza; Adnan Khan; Amber Farooqui; Muhammad Mubarak; Alex Facista; Syed Shakeel Akhtar; Saeed Khan; Javed Iqbal Kazi; Carol Bernstein; Shahana Urooj Kazmi
Journal:  Pathol Oncol Res       Date:  2014-03-25       Impact factor: 3.201

2.  Association between Helicobacter pylori genotypes and severity of chronic gastritis, peptic ulcer disease and gastric mucosal interleukin-8 levels: Evidence from a study in the Middle East.

Authors:  Iqbal Siddique; Asmaa Al-Qabandi; Jaber Al-Ali; Waleed Alazmi; Anjum Memon; Abu Salim Mustafa; Thamradeen A Junaid
Journal:  Gut Pathog       Date:  2014-09-26       Impact factor: 4.181

3.  Helicobacter pylori induces somatic mutations in TP53 via overexpression of CHAC1 in infected gastric epithelial cells.

Authors:  Yuriko Wada; Kosuke Takemura; Padmaja Tummala; Keisuke Uchida; Keisuke Kitagaki; Asuka Furukawa; Yuuki Ishige; Takashi Ito; Yukichi Hara; Takashige Suzuki; Hitomi Mimuro; Philip G Board; Yoshinobu Eishi
Journal:  FEBS Open Bio       Date:  2018-03-09       Impact factor: 2.693

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.